跳至主要内容
临床试验/IRCT2016121231362N1
IRCT2016121231362N1已完成1 期

The effect of Memantine on fatigue in patients with Multiple sclerosis: A double-blind randomized controlled clinical trial

Iranian Center of Neurological Research0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 55 years(—)
性别
All

入选标准

  • A history of multiple sclerosis (MS) for more than one year; Type of MS was Relapsing Remitting (RR); Subjective fatigue (grade 3 or 4 fatigue based on questionnaires); Age of 20-55 years; Expanded Disability Status Scale (EDSS): 0-5; Consent to participate in the study.
  • Exclusion criteria: Use of Modafinil, Ritalin or Amantadine; A history of seizure and kidney disease; Taking selective serotonin reuptake inhibitors (SSRI); Other types of diseases.

排除标准

  • 未提供

研究者

发起方
Iranian Center of Neurological Research

相似试验